Shares of Myriad Genetics Inc. (MYGN) are losing 30% to a 52-week low on Friday morning. The molecular diagnostic company on Thursday reported second-quarter results that fell short of analysts estimates and also issued a weak outlook. The company's CEO Mark Capone also resigned following the poor results.
from RTT - Earnings https://ift.tt/39j2LV0
via IFTTT
No comments:
Post a Comment